Status
Conditions
Treatments
About
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
Full description
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay.
Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move.
Aim 2. To receive participant feedback on their experience participating in the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Inability to complete 15 minutes walking unassisted
Primary purpose
Allocation
Interventional model
Masking
15 participants in 1 patient group
Loading...
Central trial contact
Kelly Clohesey Clinical Research Coordinator
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal